Genepoint Biological Technology
Genepoint Biological Technology is a healthcare Company
About Genepoint Biological Technology
Genepoint Biological Technology, established in Shanghai in July 2015, operates as a specialized provider of automated, intelligent solutions for the low-temperature preservation of biological resources. The company was founded by Chen Zhehua, who holds an MBA from Tongji University and previously served as the China Business Development Manager at Air Products (China) Investment Co., Ltd., where he was instrumental in developing the company's medical business sector. Genepoint has secured significant venture capital, with its latest Series D funding round in January 2023 raising nearly $29.5 million, led by investors such as Shanghai Guofang Private Equity Fund Management, LYFE Capital, and Huajin Capital.
The firm's business model is centered on the in-house research, development, and manufacturing of advanced cryogenic robotic systems and automated ultra-low temperature storage solutions. Its client base includes top-tier gene banks, research universities, hospitals, and biopharmaceutical facilities, primarily across Asia. Genepoint generates revenue through the sale of its specialized equipment and consumables. The company has established a strong market presence, underscored by its portfolio of over 220 patents and a research and development team that constitutes more than 32% of its workforce.
Genepoint's product suite offers comprehensive solutions for the entire bio-sample storage management process. Key offerings include the 'Hatch' series, a fully automated cryogenic robot and repository system for fast, intelligent retrieval of samples in liquid nitrogen environments. Its 'Hatch-Lite' model was recognized with the ISBER Outstanding New Product Award in 2019, a first for an Asian company in this category. Another core product, the 'Snorkel' Automated Sample Repository System, integrates advanced refrigeration technology and user-friendly intelligent interaction for efficient sample management. The 'Crest' line consists of intelligent cryogenic storage systems that maintain temperatures below -180°C using advanced vacuum extraction and insulation technology. To complement its automated systems, the company provides a range of consumables under the 'Sinfo' brand, including co-molded cryotubes designed for both automated and manual applications.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- China
- Employees
- 4
- Open positions
- None listed
- Dealroom signal
- 30.8/100
- Industry
- Health
- Sub-industry
- BioTechnology, Health Platform
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES DOther financing | Jan 2023 | $30M | $118M | Guofang Capital · LYFE Capital · Huajin Capital · Guosheng Capital | ↗ |
| SERIES COther financing | Feb 2022 | $19M | $76M | NLVC | ↗ |
Growth signals
Latest recorded traffic for Genepoint Biological Technology is 540 monthly website visits, up 1700% over the last three months. Genepoint Biological Technology's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later7 investors entered at this stage
NLVC
Guofang Capital
LYFE Capital
Huajin Capital- GCGuosheng Capital
- DCDeyi Capital
- GCGuolian Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Genepoint Biological Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Genepoint Biological Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







